Adiponectin and Insulin Resistance in Diabetic Nephropathy

• Status: Completed
• Trial end date: 2007-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Plasma adiponectin concentration is inversely associated with renal function. There is little literature on adiponectin levels and regulation by antihypertensive medication with an angiotensin II-receptor blocker (ARB), especially in subjects with type 2 diabetes in different stage of chronic kidney disease (CKD).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Health Science Center of Xi'an Jiaotong University; Health Science Center of Xi’an Jiaotong University
• Collaborator: Shanghai Jiao Tong University School of Medicine
• Treatments: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Losartan

Criteria

Inclusion Criteria:

• Type 2 diabetic nephropathy

• CKD at stage 1~4

Exclusion Criteria:

• Type 1 diabetes or nondiabetic renal disease

• An elevated plasma K level.